Suven Life Sciences
Suven Life Sciences Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Suven Life Sciences
Start SIPSuven Life Sciences Investment Rating
-
Master Rating:
-
Suven Life Sciences has an operating revenue of Rs. 13.54 Cr. on a trailing 12-month basis. An annual revenue growth of 28% is outstanding, Pre-tax margin of -874% needs improvement, ROE of -31% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 200DMA and around 5% up from its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 34 which is a POOR score indicating inconsistency in earnings, a RS Rating of 31 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 112 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 3 | 3 | 4 | 4 | 4 |
| Operating Expenses Qtr Cr | 9 | 10 | 12 | 11 | 12 |
| Operating Profit Qtr Cr | -6 | -7 | -7 | -7 | -7 |
| Depreciation Qtr Cr | 2 | 2 | 2 | 2 | 1 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | -2 | -7 | -9 | -2 | -9 |
Suven Life Sciences Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 13
- Bearish Moving Average
- ___
- 3
- 20 Day
- ₹57.11
- 50 Day
- ₹56.69
- 100 Day
- ₹57.99
- 200 Day
- ₹62.36
- 20 Day
- ₹57.46
- 50 Day
- ₹55.14
- 100 Day
- ₹57.25
- 200 Day
- ₹62.42
Suven Life Sciences Resistance and Support
| Resistance | |
|---|---|
| First Resistance | ₹59.24 |
| Second Resistance | ₹60.32 |
| Third Resistance | ₹62.09 |
| RSI | 56.52 |
| MFI | 60.44 |
| MACD Single Line | 0.3 |
| MACD | 0.22 |
| Support | |
|---|---|
| First Resistance | ₹56.39 |
| Second Resistance | ₹54.62 |
| Third Resistance | ₹53.54 |
Suven Life Sciences Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 271,088 | 16,894,204 | 62.32 |
| Week | 172,809 | 10,252,782 | 59.33 |
| 1 Month | 150,098 | 7,935,691 | 52.87 |
| 6 Month | 297,243 | 13,390,778 | 45.05 |
Suven Life Sciences Result Highlights
Suven Life Sciences Synopsis
NSE-Medical-Diversified
Suven Life Sciences is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 13.54 Cr. and Equity Capital is Rs. 21.81 Cr. for the Year ended 31/03/2023. Suven Life Sciences Ltd. is a Public Limited Listed company incorporated on 09/03/1989 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24110TG1989PLC009713 and registration number is 009713.| Market Cap | 1,270 |
| Sales | 14 |
| Shares in Float | 6.54 |
| No of funds | 15 |
| Yield | 0.89 |
| Book Value | 1.49 |
| U/D Vol ratio | 1 |
| LTDebt / Equity | |
| Alpha | -0.09 |
| Beta | 1.14 |
Suven Life Sciences
| Owner Name | Mar-23 | Dec-22 | Nov-22 | Sep-22 |
|---|---|---|---|---|
| Promoters | 69.57% | 69.57% | 64.98% | 64.98% |
| Mutual Funds | 0.01% | 0.01% | 0.01% | 0.01% |
| Foreign Portfolio Investors | 0.51% | 0.46% | 0.49% | 0.48% |
| Financial Institutions/ Banks | ||||
| Individual Investors | 23% | 22.98% | 27.43% | 27.37% |
| Others | 6.91% | 6.98% | 7.09% | 7.16% |
Suven Life Sciences Management
| Name | Designation |
|---|---|
| Mr. Venkateswarlu Jasti | Chairman & CEO |
| Mrs. Sudharani Jasti | Whole Time Director |
| Mrs. J A S Padmaja | Director |
| Prof. Seyed E Hasnain | Director |
| Mr. M Gopalakrishna | Director |
| Mr. Santanu Mukherjee | Director |
Suven Life Sciences Forecast
Price Estimates
Suven Life Sciences Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-05-09 | Audited Results | |
| 2023-02-02 | Quarterly Results | |
| 2022-11-10 | Quarterly Results | |
| 2022-10-12 | Right issue of equity shares | |
| 2022-07-26 | Quarterly Results |
Suven Life Sciences FAQs
What is Share Price of Suven Life Sciences ?
Suven Life Sciences share price is ₹58 As on 05 June, 2023 | 06:12
What is the Market Cap of Suven Life Sciences ?
The Market Cap of Suven Life Sciences is ₹1270.3 Cr As on 05 June, 2023 | 06:12
What is the P/E ratio of Suven Life Sciences ?
The P/E ratio of Suven Life Sciences is -10.7 As on 05 June, 2023 | 06:12
What is the PB ratio of Suven Life Sciences ?
The PB ratio of Suven Life Sciences is 3.4 As on 05 June, 2023 | 06:12